Plain-English translation of NCT06567886 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a consumer light therapy device called Re-Timer to see if wearing special glasses for one hour each morning can help improve sleep quality and reduce pain in people with fibromyalgia. Some participants will also try a fixed sleep schedule approach. The study will follow you for 5 months with regular virtual check-ins.
Many people with fibromyalgia struggle with sleep problems and pain that are hard to treat. Light therapy has been shown to help regulate sleep cycles in other conditions, and researchers want to see if this simple, non-medication approach might help fibromyalgia patients feel better.
You likely qualify if…
You likely don't qualify if…
You'll attend 8 virtual visits over 5 months using video conferencing. Depending on which group you're randomly assigned to, you'll either wear special light therapy glasses for 1 hour each morning for 4 weeks, follow a fixed sleep schedule for 4 weeks, or continue your normal routine. All participants will check in regularly with the research team to discuss how things are going.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States
Collaborators
National Institute of Nursing Research (NINR)
Enrollment target
~390 participants
Started
September 2024
Primary completion
March 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Helen Burgess
University of Michigan
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.